Item 8.01. Other Events.
On June 24, 2021, Applied Genetic Technologies Corporation issued a press
release reporting 12-month data from its ongoing phase 1/2 Achromatopsia (ACHM)
clinical trials. A copy of this press release is attached to this Current Report
on Form 8-K asExhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press release dated June 24, 2021.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses